$RARE DEF 14A SEC Filings

Filed On	Filing
27 Mar 2026	Proxy statement: annual meeting on May 14, 2026 CEO pay $11.4M, down 17% · say-on-pay vote
28 Mar 2025	Proxy statement: annual meeting on May 15, 2025 CEO pay $13.7M, up 4.9% · say-on-pay vote
26 Apr 2024	ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A CEO pay $13.1M, up 7.7%
24 Apr 2023	ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A CEO pay $12.1M, up 27%
28 Apr 2022	ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A
29 Apr 2021	ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A
29 Apr 2020	DEF 14A
22 Apr 2019	DEF 14A
27 Apr 2018	DEF 14A
28 Apr 2017	DEF 14A
18 Apr 2016	DEF 14A
28 Apr 2015	Proxy statement: annual meeting on June 18, 2015
23 May 2014	Proxy statement: annual meeting on July 10, 2014

Comments